1. Home
  2. ZLAB vs LILA Comparison

ZLAB vs LILA Comparison

Compare ZLAB & LILA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • LILA
  • Stock Information
  • Founded
  • ZLAB 2013
  • LILA 2017
  • Country
  • ZLAB China
  • LILA Bermuda
  • Employees
  • ZLAB N/A
  • LILA N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • LILA Cable & Other Pay Television Services
  • Sector
  • ZLAB Health Care
  • LILA Telecommunications
  • Exchange
  • ZLAB Nasdaq
  • LILA Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • LILA 1.1B
  • IPO Year
  • ZLAB 2017
  • LILA N/A
  • Fundamental
  • Price
  • ZLAB $35.49
  • LILA $6.37
  • Analyst Decision
  • ZLAB Buy
  • LILA Sell
  • Analyst Count
  • ZLAB 5
  • LILA 1
  • Target Price
  • ZLAB $54.28
  • LILA $6.50
  • AVG Volume (30 Days)
  • ZLAB 938.1K
  • LILA 344.7K
  • Earning Date
  • ZLAB 08-05-2025
  • LILA 08-05-2025
  • Dividend Yield
  • ZLAB N/A
  • LILA N/A
  • EPS Growth
  • ZLAB N/A
  • LILA N/A
  • EPS
  • ZLAB N/A
  • LILA N/A
  • Revenue
  • ZLAB $418,326,000.00
  • LILA $4,441,000,000.00
  • Revenue This Year
  • ZLAB $44.07
  • LILA $2.45
  • Revenue Next Year
  • ZLAB $49.13
  • LILA $3.11
  • P/E Ratio
  • ZLAB N/A
  • LILA N/A
  • Revenue Growth
  • ZLAB 43.72
  • LILA N/A
  • 52 Week Low
  • ZLAB $16.01
  • LILA $4.26
  • 52 Week High
  • ZLAB $44.34
  • LILA $10.82
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 49.61
  • LILA 72.77
  • Support Level
  • ZLAB $34.55
  • LILA $5.69
  • Resistance Level
  • ZLAB $36.73
  • LILA $5.97
  • Average True Range (ATR)
  • ZLAB 1.31
  • LILA 0.22
  • MACD
  • ZLAB -0.56
  • LILA 0.09
  • Stochastic Oscillator
  • ZLAB 10.59
  • LILA 97.54

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About LILA Liberty Latin America Ltd.

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

Share on Social Networks: